Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 961.65
+11.85 (1.25%)
Aug 21, 2026, 3:29 PM IST
Remus Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 369.9 | 290.7 | 205.2 | 85.03 | 34.34 |
Depreciation & Amortization | 27.6 | 18.6 | 11 | 4.64 | 1.55 |
Other Amortization | - | 0.1 | 0.2 | 0.13 | - |
Loss (Gain) From Sale of Assets | -0.2 | -2.1 | - | - | - |
Loss (Gain) From Sale of Investments | 2.9 | - | - | - | - |
Other Operating Activities | 118.1 | 93.6 | 21.7 | -3.93 | -1.72 |
Change in Accounts Receivable | -318.1 | 72.6 | -481.2 | -19.33 | 6.89 |
Change in Inventory | -205 | -84.4 | -7.7 | 13.02 | -4.39 |
Change in Accounts Payable | 47.6 | -224.1 | 390.2 | -15.07 | 14.97 |
Change in Other Net Operating Assets | 138.8 | -95.2 | -125.9 | -11.36 | -1.26 |
Operating Cash Flow | 181.6 | 69.8 | 13.5 | 53.13 | 50.38 |
Operating Cash Flow Growth | 160.17% | 417.04% | -74.59% | 5.46% | 77.52% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -145.7 | -39.8 | -32.9 | -27.32 | -0.71 |
Sale of Property, Plant & Equipment | 8.8 | 3 | - | - | - |
Cash Acquisitions | - | - | -87.3 | - | - |
Investment in Securities | -188.6 | 2.7 | 32.6 | -175.48 | -30.01 |
Other Investing Activities | 62.4 | -42.5 | -178.3 | 3.45 | 2.44 |
Investing Cash Flow | -150.3 | -105.5 | -301.1 | -151.92 | -45.45 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 89.3 | - | - | - |
Long-Term Debt Issued | 41.9 | 3.3 | 23.5 | 77.51 | - |
Total Debt Issued | 41.9 | 92.6 | 23.5 | 77.51 | - |
Short-Term Debt Repaid | -1.1 | - | -6.4 | - | - |
Long-Term Debt Repaid | - | -5.1 | -58.6 | - | -0.87 |
Total Debt Repaid | -1.1 | -5.1 | -65 | - | -0.87 |
Net Debt Issued (Repaid) | 40.8 | 87.5 | -41.5 | 77.51 | -0.87 |
Issuance of Common Stock | - | - | 467 | 42.5 | - |
Common Dividends Paid | -11.8 | -11.8 | -5.9 | - | - |
Other Financing Activities | -14.3 | -15 | -142.9 | -2.33 | -0.87 |
Financing Cash Flow | 14.7 | 60.7 | 276.7 | 117.69 | -1.74 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | -0.1 | 0.1 | 48 | 0 | - |
Net Cash Flow | 45.9 | 25.1 | 37.1 | 18.9 | 3.18 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 35.9 | 30 | -19.4 | 25.81 | 49.67 |
Free Cash Flow Growth | 19.67% | - | - | -48.03% | 79.21% |
Free Cash Flow Margin | 0.42% | 0.48% | -0.91% | 5.72% | 20.09% |
Free Cash Flow Per Share | 3.80 | 2.55 | -1.72 | 3.16 | 6.21 |
Levered Free Cash Flow | 25.28 | -108.75 | -394.05 | 7.45 | 42.87 |
Unlevered Free Cash Flow | 34.46 | -99.63 | -390.92 | 8.73 | 43.36 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 14.7 | 14.6 | 5 | 2.33 | 0.87 |
Cash Income Tax Paid | 94.6 | 74.7 | 58.1 | 29.97 | 11.94 |
Change in Working Capital | -336.7 | -331.1 | -224.6 | -32.74 | 16.21 |